Summary
No longer available (Autolink)
See the full content of this document
Extract
A new framework for assessing clinical data transparency initiatives.
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 419 F.Supp. 1318 (S.D.N.Y. 1975), 75 CR. 753, United States v. Pastor
- Federal Cases - 803 F.2d 378 (8th Cir. 1986), 85-1713, A.L. Laboratories, Inc. v. Philips Roxane, Inc.
- Federal Cases - 259 F.3d 587 (7th Cir. 2001), 00-3021, MN Mining & Manufacturing Co. v. Pribyl
- Federal Cases - 344 F.3d 1294 (11th Cir. 2003), 02-12091, Valley Drug Co. v. Geneva Pharmaceuticals, Inc.
- Federal Cases - 6 F.2d 491 (D.D.C. 1925), 4168, United States ex rel. Norwegian Nitrogen Products Co., Inc. v. United States Tariff Commission